Insights
Search Results
Client Highlights
5.07.26
Wilson Sonsini Advises Astranis on $450 Million Fundraise
On May 6, 2026, Astranis, an advanced satellite manufacturer, announced it has raised $450 million in new capital, bringing the company’s total raised to more than $1.2 billion as it scales to meet increased demand for its spacecraft designed for geostationary orbit and other high orbits. The funding includes a new $300 million Series E round co-led by Snowpoint Ventures and Franklin Templeton, with participation from Andreessen Horowitz, funds and accounts managed by affiliates of BlackRock, Baillie Gifford, and Fidelity Management & Research Company, as well as BAM Elevate, Nimble Partners, and Friends & Family Capital, along with other existing and new investors. A delayed-draw credit facility by Trinity Capital adds up to $155 million of additional capital to support the addition of new manufacturing capacity and support future growth. Wilson Sonsini Goodrich & Rosati advised Astranis on the transactions.
Client Highlights
4.17.26
Firm Advises Neurona Therapeutics on Acquisition by UCB
On April 17, 2026, UCB, a global biopharmaceutical company, announced that it has entered into a definitive agreement under which UCB would acquire Neurona Therapeutics, including lead asset NRTX-1001, adding to UCB’s epilepsy portfolio. Neurona Therapeutics is a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for epilepsies and other disorders of the nervous system. Under the terms of the agreement, UCB will pay $650 million upfront and up to $500 million in potential future milestone payments, subject to certain closing conditions. Wilson Sonsini Goodrich & Rosati advised Neurona on the transaction.
Client Highlights
3.30.26
Wilson Sonsini Advises Octopus Energy on Majority Stake Acquisition of Uplight
On March 24, 2026, Octopus Energy Group, a global clean energy and technology business driving the affordable, green energy system of the future, will cement its expansion in the U.S. by acquiring a majority stake in Uplight, a leading provider of customer engagement and flexibility management solutions that rapidly transform customer participation into dependable grid capacity. The deal is made in partnership with Schneider Electric, a global energy technology leader trusted by utilities worldwide, which will remain as a significant minority partner. The transaction is subject to customary regulatory approvals and is expected to complete later this year. Wilson Sonsini Goodrich & Rosati advised Octopus Energy on the transaction.
Client Highlights
3.13.26
Wilson Sonsini Advises Urgently on Acquisition by Agero
On March 13, 2026, Agero, a software-enabled driver safety services and technology company, announced that it has entered into an agreement to acquire Urgent.ly (Urgently), a digital software platform that provides roadside and mobility assistance, for a cash price of $5.50 per share. The tender offer and merger are expected to close by the end of May 2026, subject to satisfaction of customary closing conditions. Wilson Sonsini Goodrich & Rosati advised Urgently on the transaction.
Client Highlights
1.23.26
Wilson Sonsini Advises Brex on $5.15 Billion Acquisition by Capital One
On January 22, 2026, Capital One announced that it has entered into a definitive agreement to acquire Brex, in a combination of stock and cash transaction valued at $5.15 billion. Brex is a modern, AI-native software platform offering intelligent finance solutions that make it easy for businesses to issue corporate cards, automate expense management, and make secure, real-time payments. The transaction is expected to close in the middle of 2026, subject to customary closing conditions. Wilson Sonsini Goodrich & Rosati advised Brex on the transaction.
Client Highlights
1.07.26
Wilson Sonsini Advises OneStream on Acquisition by Hg
On January 6, 2026, OneStream, the leading enterprise finance management platform, announced that it has entered into a definitive agreement to be acquired by Hg, a leading investor in software, services, and data businesses. The all-cash transaction values OneStream at approximately $6.4 billion in equity value. Wilson Sonsini Goodrich & Rosati advised OneStream on this transaction in a continuation of its long-standing advisory relationship with the company, including leading OneStream’s Up-C IPO in July 2024.
Client Highlights
11.26.25
Wilson Sonsini Advises Revival Healthcare Capital on $150 Million Series G Financing of Distalmotion SA
On November 17, 2025, Revival Healthcare Capital and Distalmotion SA, a global medical device company based in Lausanne, Switzerland, and empowering access to the benefits of robotic surgery in outpatient sites of care, announced the successful closing of a $150 million Series G financing round of Distalmotion SA led by Revival Healthcare Capital, with participation from existing investors. Wilson Sonsini Goodrich & Rosati advised Revival Healthcare Capital on the fundraise.
Client Highlights
11.04.25
Firm Advises Automation Anywhere on Acquisition of Aisera
On November 4, 2025, Automation Anywhere, the leading provider of Agentic Process Automation (APA) and agentic solutions, announced it has acquired Aisera, the leading provider of agentic solutions for autonomous IT. The acquisition expands Automation Anywhere’s deep AI portfolio and expertise in automating mission-critical enterprise processes with Aisera’s industry-leading self-service agents for IT Service Management (ITSM), HR, and Customer Service—creating the industry’s most comprehensive agentic automation portfolios to deliver autonomous operations across departments and improve employee and customer experience. Wilson Sonsini Goodrich & Rosati advised Automation Anywhere on the transaction.
Client Highlights
10.17.25
Wilson Sonsini Advises Omeros on Asset Purchase and License Agreement with Novo Nordisk
On October 15, 2025, Novo Nordisk and Omeros Corporation announced that they have entered into a definitive asset purchase and license agreement for the candidate drug zaltenibart (OMS906) in clinical development for rare blood and kidney disorders. Wilson Sonsini Goodrich & Rosati advised Omeros on the transaction.
Client Highlights
10.13.25
Wilson Sonsini Advises Fivetran on Merger with dbt Labs
On October 13, 2025, Fivetran, a global leader in automated data movement, announced that it signed a definitive agreement to merge with dbt Labs, a pioneer of modern data transformation, in an all-stock deal. The combined company will be approaching $600 million in annual recurring revenue. The transaction marks significant consolidation in the data tooling market as enterprises race to adapt infrastructure for artificial intelligence applications. Wilson Sonsini Goodrich & Rosati advised Fivetran on the transaction.
Client Highlights
10.02.25
Wilson Sonsini Advises Kodiak AI on Completed Business Combination with Ares Acquisition Corporation II
On September 29, 2025, Kodiak AI, a leading provider of AI-powered autonomous vehicle technology, announced that Kodiak Robotics, Inc. successfully completed its business combination with Ares Acquisition Corporation II (AACT), a publicly traded special purpose acquisition company. The business combination was approved by AACT shareholders on September 23, 2025. In connection with the closing, AACT was renamed Kodiak AI. Kodiak AI’s common stock and public warrants began trading on Nasdaq on September 25, 2025, under the ticker symbols “KDK” and “KDKRW,” respectively. Wilson Sonsini Goodrich & Rosati advised Kodiak AI on the transaction.
Client Highlights
6.30.25
Wilson Sonsini Advises Clio on $1 Billion Acquisition of vLex
On June 30, 2025, Clio, the world's leading provider of legal technology, announced it has signed a definitive agreement to acquire vLex, a pioneer in legal intelligence that combines cutting-edge AI with the world's most comprehensive global legal research platform. The transaction is valued at $1 billion and will be paid in a combination of cash and stock. Wilson Sonsini Goodrich & Rosati is advising Clio on the transaction.